Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Seeing thyroid cancer in a new light: when AI meets label-free imaging in the operating room
Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection…
Survival outcomes in young adults with metastatic colorectal cancer vary by socioeconomic context
A large cohort study published in JAMA Network Open has documented significant disparities in survival…
Gut bacteria from tree frogs: unexplored biodiversity could represent a treasure trove for novel medical technology
A research team of Prof. Eijiro Miyako at the Japan Advanced Institute of Science and Technology (JAIST)…
Raising Awareness of Oral Cancers
How common are oral cancers? Why is early detection important? Do GPs and Dentists have enough awareness of these cancers?
Our Host Rachael Babin discusses these issues with surgeon Professor David Wiesenfeld from Melbourne, Australia.
ASCO GU 2024: Subcutaneous nivolumab as effective as IV for renal cell carcinoma with much faster treatment time
- ASCO GU 2024: Combination of cabozantinib and atezolizumab offers hope for patients with type of advanced prostate cancer with poor prognosis
- Prostate cancer: Newly-developed inhibitor shows massive potential
- Association of molecular subtypes in bladder cancer with response to neoadjuvant chemotherapy, progression, and survival
Could a single drug treat the two leading causes of death in the US: cancer and cardiovascular disease?
Bryan Smith, Michigan State University What would you guess are the two biggest killers in the world? Based on media…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.